International Journal of Cancer Management

Published by: Kowsar

Elevated Serum 8-Hydroxy-2’-Deoxyguanosine, Nitrite, and Nitrate in Patients with Stage I Multiple Myeloma

Mohammad-Hassan Khadem-Ansari 1 , Samira Nozari 2 , Mojtaba Asoudeh 1 , Yousef Rasmi 1 and Yousef Faridvand 3 , *
Authors Information
1 Department of Clinical Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran
2 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3 Department of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Article information
  • International Journal of Cancer Management: October 2017, 10 (10); e8493
  • Published Online: October 28, 2017
  • Article Type: Research Article
  • Received: September 25, 2016
  • Revised: November 13, 2016
  • Accepted: December 12, 2016
  • DOI: 10.5812/ijcm.8493

How to Cite: Khadem-Ansari M, Nozari S, Asoudeh M, Rasmi Y, Faridvand Y. Elevated Serum 8-Hydroxy-2’-Deoxyguanosine, Nitrite, and Nitrate in Patients with Stage I Multiple Myeloma, Int J Cancer Manag. 2017 ; 10(10):e8493. doi: 10.5812/ijcm.8493.

Copyright © 2017, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Furukawa Y, Kikuchi J. Molecular pathogenesis of multiple myeloma. Int J Clin Oncol. 2015;20(3):413-22. doi: 10.1007/s10147-015-0837-0. [PubMed: 25953678].
  • 2. Chesi M, Bergsagel PL. Molecular pathogenesis of multiple myeloma: Basic and clinical updates. Int J Hematol. 2013;97(3):313-23. doi: 10.1007/s12185-013-1291-2. [PubMed: 23456262].
  • 3. Kumar S. Treatment of newly diagnosed multiple myeloma: Advances in current therapy. Med Oncol. 2010;27 Suppl 1:14-24. doi: 10.1007/s12032-009-9370-1. [PubMed: 20035387].
  • 4. Karihtala P, Soini Y. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. Acta Pathol, Microbiol, Immunol Scand. 2007;115(2):81-103. doi: 10.1111/j.1600-0463.2007.apm_514.x. [PubMed: 17295675].
  • 5. Durackova Z. Some current insights into oxidative stress. Physiol Res. 2010;59(4):459-69. [PubMed: 19929132].
  • 6. Jabs T. Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol. 1999;57(3):231-45. doi: 10.1016/s0006-2952(98)00227-5.
  • 7. Mossman BT. Introduction to serial reviews on the role of reactive oxygen and nitrogen species (ROS/RNS) in lung injury and diseases. Free Radical Biol Med. 2003;34(9):1115-6. doi: 10.1016/s0891-5849(03)00061-3.
  • 8. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem J. 1996;313 ( Pt 1):17-29. [PubMed: 8546679].
  • 9. Ames BN, Shigenaga MK, Gold LS. DNA lesions, inducible DNA repair, and cell division: Three key factors in mutagenesis and carcinogenesis. Environ Health Perspect. 1993;101 Suppl 5:35-44. [PubMed: 8013423].
  • 10. Kasai H, Kawai K. Oxidative DNA damage: mechanisms and significance in health and disease. Antioxid Redox Signal. 2006;8(5-6):981-3. doi: 10.1089/ars.2006.8.981. [PubMed: 16771687].
  • 11. Barzilai A, Yamamoto K. DNA damage responses to oxidative stress. DNA Repair (Amst). 2004;3(8-9):1109-15. doi: 10.1016/j.dnarep.2004.03.002. [PubMed: 15279799].
  • 12. Scott TL, Rangaswamy S, Wicker CA, Izumi T. Repair of oxidative DNA damage and cancer: recent progress in DNA base excision repair. Antioxid Redox Signal. 2014;20(4):708-26. doi: 10.1089/ars.2013.5529. [PubMed: 23901781].
  • 13. Levine RL. Carbonyl modified proteins in cellular regulation, aging, and disease2,3 2guest editor: Earl stadtman 3this article is part of a series of reviews on “oxidatively modified proteins in aging and disease.” the full list of papers may be found on the homepage of the journal. Free Radical Biol Med. 2002;32(9):790-6. doi: 10.1016/s0891-5849(02)00765-7.
  • 14. Lohr JG, Stojanov P, Carter SL, Cruz-Gordillo P, Lawrence MS, Auclair D, et al. Widespread genetic heterogeneity in multiple myeloma: Implications for targeted therapy. Cancer Cell. 2014;25(1):91-101. doi: 10.1016/j.ccr.2013.12.015. [PubMed: 24434212].
  • 15. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: A marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 2004;339(1-2):1-9. [PubMed: 14687888].
  • 16. Waris G, Ahsan H. Reactive oxygen species: Role in the development of cancer and various chronic conditions. J Carcinog. 2006;5:14. doi: 10.1186/1477-3163-5-14. [PubMed: 16689993].
  • 17. Caers J, Van Valckenborgh E, Menu E, Van Camp B, Vanderkerken K. Unraveling the biology of multiple myeloma disease: Cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environment. Bull Cancer. 2008;95(3):301-13. doi: 10.1684/bdc.2008.0600. [PubMed: 18390410].
  • 18. Visconti R, Grieco D. New insights on oxidative stress in cancer. Curr Opin Drug Discovery Dev. 2009;12(2):240-5. [PubMed: 19333869].
  • 19. Sesti F, Tsitsilonis OE, Kotsinas A, Trougakos IP. Oxidative stress-mediated biomolecular damage and inflammation in tumorigenesis. In Vivo. 2012;26(3):395-402. [PubMed: 22523291].
  • 20. Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: Role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch Surg. 2006;391(5):499-510. doi: 10.1007/s00423-006-0073-1. [PubMed: 16909291].
  • 21. Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer. 2007;121(11):2381-6. doi: 10.1002/ijc.23192. [PubMed: 17893868].
  • 22. Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC, et al. Initial genome sequencing and analysis of multiple myeloma. Nature. 2011;471(7339):467-72. doi: 10.1038/nature09837. [PubMed: 21430775].
  • 23. Liu B, Chen Y, St Clair DK. ROS and p53: A versatile partnership. Free Radic Biol Med. 2008;44(8):1529-35. doi: 10.1016/j.freeradbiomed.2008.01.011. [PubMed: 18275858].
  • 24. Sharma A, Tripathi M, Satyam A, Kumar L. Study of antioxidant levels in patients with multiple myeloma. Leuk Lymphoma. 2009;50(5):809-15. doi: 10.1080/10428190902802323. [PubMed: 19452319].
  • 25. Kuku I, Aydogdu I, Bayraktar N, Kaya E, Akyol O, Erkurt MA. Oxidant/antioxidant parameters and their relationship with medical treatment in multiple myeloma. Cell Biochem Funct. 2005;23(1):47-50. doi: 10.1002/cbf.1127. [PubMed: 15386538].
  • 26. Gangemi S, Allegra A, Alonci A, Cristani M, Russo S, Speciale A, et al. Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions. Inflamm Res. 2012;61(10):1063-7. doi: 10.1007/s00011-012-0498-7. [PubMed: 22674324].
  • 27. Ellidag HY, Aydin O, Eren E, Yilmaz N, Ergin M. Decreased HDL-dependent paraoxonase and arylesterase enzyme activity may indicate a worse prognosis in multiple myeloma. Asian Pac J Cancer Prev. 2014;15(22):9847-51. [PubMed: 25520116].
  • 28. Khadem-Ansari MH, Shahsavari Z, Rasmi Y, Mahmoodlo R. Elevated levels of urinary 8-hydroxy-2'-deoxyguanosine and 8-isoprostane in esophageal squamous cell carcinoma. J Carcinog. 2011;10:14. doi: 10.4103/1477-3163.79683. [PubMed: 21712961].
  • 29. Diakowska D, Lewandowski A, Kopec W, Diakowski W, Chrzanowska T. Oxidative DNA damage and total antioxidant status in serum of patients with esophageal squamous cell carcinoma. Hepatogastroenterology. 2007;54(78):1701-4. [PubMed: 18019698].
  • 30. Crohns M, Saarelainen S, Erhola M, Alho H, Kellokumpu-Lehtinen P. Impact of radiotherapy and chemotherapy on biomarkers of oxidative DNA damage in lung cancer patients. Clin Biochem. 2009;42(10-11):1082-90. doi: 10.1016/j.clinbiochem.2009.02.022. [PubMed: 19272366].
  • 31. Wei YC, Zhou FL, He DL, Bai JR, Hui LY, Wang XY, et al. The level of oxidative stress and the expression of genes involved in DNA-damage signaling pathways in depressive patients with colorectal carcinoma. J Psychosom Res. 2009;66(3):259-66. doi: 10.1016/j.jpsychores.2008.09.001. [PubMed: 19232240].
  • 32. Cobanoglu U, Demir H, Cebi A, Sayir F, Alp HH, Akan Z, et al. Lipid peroxidation, DNA damage and coenzyme Q10 in lung cancer patients--markers for risk assessment?. Asian Pac J Cancer Prev. 2011;12(6):1399-403. [PubMed: 22126471].
  • 33. Ito K, Yano T, Morodomi Y, Yoshida T, Kohno M, Haro A, et al. Serum antioxidant capacity and oxidative injury to pulmonary DNA in never-smokers with primary lung cancer. Anticancer Res. 2012;32(3):1063-7. [PubMed: 22399633].
  • 34. Patel RP, McAndrew J, Sellak H, White CR, Jo H, Freeman BA, et al. Biological aspects of reactive nitrogen species. Biochimica Biophysica Acta. 1999;1411(2-3):385-400. doi: 10.1016/s0005-2728(99)00028-6.
  • 35. Bakan E, Taysi S, Polat MF, Dalga S, Umudum Z, Bakan N, et al. Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol. 2002;32(5):162-6. [PubMed: 12110642].
  • 36. Beevi SS, Rasheed AM, Geetha A. Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer. Jpn J Clin Oncol. 2004;34(7):379-85. doi: 10.1093/jjco/hyh058. [PubMed: 15342664].
  • 37. Gonenc A, Hacisevki A, Aslan S, Torun M, Simsek B. Increased oxidative DNA damage and impaired antioxidant defense system in patients with gastrointestinal cancer. Eur J Intern Med. 2012;23(4):350-4. doi: 10.1016/j.ejim.2012.02.001. [PubMed: 22560384].
  • 38. Faridvand Y, Oskuyi AE, Khadem-Ansari MH. Serum 8-isoprostane levels and paraoxonase 1 activity in patients with stage I multiple myeloma. 2015.
  • 39. Mehdi WA, Zainulabdeen JA, Mehde AA. Investigation of the antioxidant status in multiple myeloma patients: Effects of therapy. Asian Pac J Cancer Prev. 2013;14(6):3663-7. [PubMed: 23886162].
  • 40. Lodh M, Goswami B, Gupta N, Patra SK, Saxena A. Assessment of oxidative stress and inflammatory process in patients of multiple myeloma. Indian J Clin Biochem. 2012;27(4):410-3. doi: 10.1007/s12291-012-0222-y. [PubMed: 24082470].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments